MIT working on hydrogel tech for battlefield wounds; BioDelivery Sciences and Endo discuss candidate with FDA;

> MIT researcher Brad Olsen, along with two co-workers, is working to develop an injectable hydrogel for use on battlefield wounds. Story

> BioDelivery Sciences International ($BDSI) and Endo Pharmaceuticals ($ENDP) met with the FDA on July 15 to discuss BEMA Buprenorphine for severe pain management. Release

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.